Dr. Braddock has made important contributions to the understanding of the histopathology of disorders of aberrant calcification. As the scientific founder of Inozyme and the Chairperson of the Scientific Advisory Board, Dr. Braddock continues to collaborate with the company. Dr. Braddock was educated at the University of Chicago and trained at the National Institutes of Health in Pathology and Chemical Physics.